EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2024 • Clearside Biomedical, Inc. • Pharmaceutical preparations • Georgia
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”), is entered into effective as of June 19, 2024, (the “Effective Date”), by and between Clearside Biomedical, Inc., a Delaware corporation (the “Company”), and Victor Chong (the “Executive”), an individual residing in California.
AMENDMENT 1 TO THE LICENSE AGREEMENTLicense Agreement • August 12th, 2024 • Clearside Biomedical, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT to the LICENSE AGREEMENT (the “Amendment”) is made and entered into on this 20th day of May 2024 (the “Amendment Effective Date”), by and between BioCryst Pharmaceuticals, Inc. (“BioCryst”) and Clearside Biomedical, Inc. (“Clearside”). All undefined terms contained herein shall have the meaning set forth in the Agreement.
